Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study Using Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases

NCT04812470 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT04812470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04812470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study Using Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases
Lead sponsor
Vastra Gotaland Region
Phase
Phase 1
Overall status
Completed
Start date
February 6, 2023
Completion date
May 26, 2025
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cutaneous melanoma, metastatic uveal melanoma